SPDR S&P Biotech ETF $XBI Shares Sold by Osborne Partners Capital Management LLC

Osborne Partners Capital Management LLC reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 180,964 shares of the exchange traded fund’s stock after selling 6,601 shares during the period. SPDR S&P Biotech ETF comprises 1.1% of Osborne Partners Capital Management LLC’s portfolio, making the stock its 21st largest position. Osborne Partners Capital Management LLC owned 0.27% of SPDR S&P Biotech ETF worth $22,065,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Davis Capital Management acquired a new position in shares of SPDR S&P Biotech ETF during the third quarter worth $35,000. Barnes Dennig Private Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at $48,000. Halbert Hargrove Global Advisors LLC acquired a new stake in SPDR S&P Biotech ETF in the third quarter valued at $40,000. Premier Financial Group acquired a new stake in SPDR S&P Biotech ETF in the third quarter valued at $50,000. Finally, Family CFO Inc acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at $64,000.

SPDR S&P Biotech ETF Price Performance

XBI opened at $137.79 on Tuesday. The stock has a market capitalization of $9.09 billion, a PE ratio of 11.47 and a beta of 0.88. The firm’s fifty day moving average price is $126.58 and its 200 day moving average price is $121.26. SPDR S&P Biotech ETF has a 12-month low of $74.67 and a 12-month high of $139.19.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.